Skip to content

#Mechanisms

19 NovThu
26 OctMon
  1. ClinicalTrials.gov: newly registered trials42

    Double-blind randomised trial tests three ayahuasca doses against placebo on personality in 28 healthy volunteers

    A double-blind, randomised, placebo-controlled trial registered on ClinicalTrials.gov assigned 28 healthy volunteers to four single-dose groups of seven: ayahuasca 0.5 mL/kg, 1.0 mL/kg, 1.5 mL/kg or placebo. The study examined effects on personality. No results are reported in the registration entry.

19 SepSat
  1. Europe PMC: new psychedelic research papers52

    Review examines psychedelics and suicidality as a double-edged sword

    A review examines the relationship between classic psychedelics such as LSD, psilocybin and DMT and suicidality, proposing a theoretical double-edged sword model. The authors report that several deaths followed non-medical psychedelic use in unsafe contexts, with unclear suicidal intent, and that rare cases of increased suicidal ideation and behaviours in clinical settings showed no significant differences from placebo groups or established causality.

6 SepSun
  1. Europe PMC: new psychedelic research papers60

    Systematic review examines the effect of psychedelics on associative learning

    A systematic review of 62 studies, only 2 in humans, reports that psychedelic administration appears to enhance associative learning in animals across conditioning paradigms, though findings were not consistent. The authors write that direct evidence of enhanced associative learning in humans remains limited, while human studies show altered cognitive flexibility and learning-related processes.

    Why it matters: The review separates animal evidence of enhanced associative learning from the limited human data, a distinction that matters for claims about the post-acute window used in psychedelic-assisted psychotherapy.